Mexico - North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Size & Outlook
The veterinary active pharmaceutical ingredients manufacturing market in Mexico - North America is expected to reach a projected revenue of US$ 372.6 million by 2033. A compound annual growth rate of 7.9% is expected of Mexico - North America veterinary active pharmaceutical ingredients manufacturing market from 2025 to 2033.
Mexico veterinary active pharmaceutical ingredients manufacturing market highlights
The Mexico veterinary active pharmaceutical ingredients manufacturing market generated a revenue of USD 187.3 million in 2024 and is expected to reach USD 372.6 million by 2033.
The Mexico market is expected to grow at a CAGR of 7.9% from 2025 to 2033.
In terms of segment, in house was the largest revenue generating service type in 2024.
Contract Outsourcing is the most lucrative service type segment registering the fastest growth during the forecast period.
Veterinary active pharmaceutical ingredients manufacturing market data book summary
Market revenue in 2024
USD 187.3 million
Market revenue in 2033
USD 372.6 million
Growth rate
7.9% (CAGR from 2025 to 2033)
Largest segment
In house
Fastest growing segment
Contract Outsourcing
Historical data
2021 - 2023
Base year
2024
Forecast period
2025 - 2033
Quantitative units
Revenue in USD million
Market segmentation
In House, Contract Outsourcing
Key market players worldwide
Zoetis Inc Class A, SeQuent Scientific, Ofichem Group, The Chem-Pro Group, Siflon Drugs & Pharmaceuticals, Vetpharma, Suanfarma Biotech, Menadiona, Excel Industries
Other key industry trends
In terms of revenue, Mexico accounted for 2.0% of the global veterinary active pharmaceutical ingredients manufacturing market in 2024.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
In North America, U.S. veterinary active pharmaceutical ingredients manufacturing market is projected to lead the regional market in terms of revenue in 2033.
Mexico is the fastest growing regional market in North America and is projected to reach USD 372.6 million by 2033.
Mexico - North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook will help companies and investors design strategic landscapes.
In House was the largest segment with a revenue share of 63.91% in 2024.
Horizon Databook has segmented the Mexico - North America veterinary active pharmaceutical ingredients manufacturing market based on in house, contract outsourcing covering the revenue growth of each sub-segment from 2021 to 2033.
Mexico - North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Service Type Outlook (Revenue, USD Million , 2021-2033)
In House
Contract Outsourcing
Mexico - North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Synthesis Type Outlook (Revenue, USD Million , 2021-2033)
Chemical Based API
Biological API
HPAPI
Mexico - North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Therapeutic Category Outlook (Revenue, USD Million , 2021-2033)
Antiparasitics
Anti-infectives
NSAIDs
Others
Mexico - North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Animal Type Outlook (Revenue, USD Million , 2021-2033)
Companion Animals
Production Animals
Reasons to subscribe to Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook databook
Our clientele includes a mix of Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Mexico - North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Mexico - North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Mexico - North America Veterinary Active Pharmaceutical Ingredients Manufacturing Market, 2021-2033 (US$M)